ClearPoint Neuro, Inc.CLPTEarnings & Financial Report
ClearPoint Neuro, Inc. is a medical technology firm specializing in precision neurology solutions. It develops and commercializes intraoperative navigation, targeting and delivery systems for minimally invasive brain surgeries, neurological disorder treatments, and CNS therapy development for global clinical and biopharmaceutical partners.
Revenue
$9.2M
Gross Profit
$5.6M
Operating Profit
$-5.7M
Net Profit
$-5.8M
Gross Margin
60.3%
Operating Margin
-61.6%
Net Margin
-63.3%
YoY Growth
17.3%
EPS
$-0.21
ClearPoint Neuro, Inc. Q2 FY2025 Financial Summary
ClearPoint Neuro, Inc. reported revenue of $9.2M (up 17.3% YoY) for Q2 FY2025, with a net profit of $-5.8M (down 32.4% YoY) (-63.3% margin). Cost of goods sold was $3.7M, operating expenses totaled $11.2M.
Key Financial Metrics
| Total Revenue | $9.2M |
|---|---|
| Net Profit | $-5.8M |
| Gross Margin | 60.3% |
| Operating Margin | -61.6% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
ClearPoint Neuro, Inc. Q2 FY2025 revenue of $9.2M breaks down across 3 segments, led by Biologics And Drug Delivery at $4.7M (51.4% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Biologics And Drug Delivery | $4.7M | 51.4% |
| Neurosurgery Navigation And Therapy Disposable Products | $3.4M | 37.2% |
| Capital Equipment And Software | $1.0M | 11.3% |
ClearPoint Neuro, Inc. Revenue by Segment — Quarterly Trend
ClearPoint Neuro, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Biologics And Drug Delivery and Neurosurgery Navigation And Therapy Disposable Products) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Biologics And Drug Delivery | — | — | $4.7M | $4.7M |
| Neurosurgery Navigation And Therapy Disposable Products | $4.7M | $3.4M | $3.4M | $3.3M |
| Capital Equipment And Software | — | — | $1.0M | — |
ClearPoint Neuro, Inc. Annual Revenue by Year
ClearPoint Neuro, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $37.0M).
| Year | Annual Revenue |
|---|---|
| 2025 | $37.0M |
| 2024 | $31.4M |
| 2023 | $24.0M |
| 2022 | $20.6M |
ClearPoint Neuro, Inc. Quarterly Revenue & Net Profit History
ClearPoint Neuro, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $10.4M | +34.0% | N/A | N/A |
| Q3 FY2025 | $8.9M | +9.1% | $-5.9M | -66.5% |
| Q2 FY2025 | $9.2M | +17.3% | $-5.8M | -63.3% |
| Q1 FY2025 | $8.5M | +11.1% | $-6.0M | -71.0% |
| Q4 FY2024 | $7.8M | +14.1% | N/A | N/A |
| Q3 FY2024 | $8.1M | +41.0% | $-5.0M | -61.2% |
| Q2 FY2024 | $7.9M | +32.1% | $-4.4M | -56.1% |
| Q1 FY2024 | $7.6M | +40.6% | $-4.1M | -54.3% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.6M | $7.9M | $8.1M | $7.8M | $8.5M | $9.2M | $8.9M | $10.4M |
| YoY Growth | 40.6% | 32.1% | 41.0% | 14.1% | 11.1% | 17.3% | 9.1% | 34.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $53.6M | $52.6M | $40.2M | $39.2M | $30.1M | $62.9M | $60.4M | $97.7M |
| Liabilities | $19.1M | $20.4M | $11.2M | $13.8M | $10.1M | $43.1M | $44.5M | $69.7M |
| Equity | $34.6M | $32.1M | $29.0M | $25.4M | $20.0M | $19.7M | $15.9M | $28.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-3.8M | $-2.7M | $-1.2M | $-1.2M | $-6.2M | $-2.6M | $-3.1M | $-12.1M |